- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04217239
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
A Comparison of Short-term and Long- Term Outcomes Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical approaches:
MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250033
- Recruiting
- Yunpeng Zhao
-
Contact:
- Yunpeng Zhao
- Phone Number: +8618766188692
- Email: zyp_baggio@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
(I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary function;
(II) Patients with lower thoracic esophageal tumors and esophageal- gastric junction tumor;
(III) Patients without a previous history of cancer;
(IV) Patients without a previous history of neck or chest surgery;
Exclusion Criteria:
(I) cardiopulmonary function not good enough for surgery;
(II) Patients with hybrid MIE
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ivor-Lewis group
minimally invasive esophagectomy (MIE) with intrathoracic anastomosis
|
minimally invasive esophagectomy (MIE) with intrathoracic anastomosis
|
Active Comparator: McKeown group
minimally invasive esophagectomy (MIE) with cervical anastomosis
|
minimally invasive esophagectomy (MIE) with cervical anastomosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Operating time
Time Frame: 1 day
|
Operating time in minutes
|
1 day
|
Blood loss
Time Frame: 1 day
|
Blood loss in milliliter
|
1 day
|
Lymph nodes harvested
Time Frame: 1 day
|
Lymph nodes harvested in number
|
1 day
|
Pulmonary complication
Time Frame: 1 month
|
Pulmonary complication in rate
|
1 month
|
Anastomotic leakage
Time Frame: within one month
|
Anastomotic leakage in rate
|
within one month
|
Anastomotic stenosis
Time Frame: within three months
|
Anastomotic stenosis in rate
|
within three months
|
recurrent laryngeal nerve injury
Time Frame: within three months
|
recurrent laryngeal nerve injury in rate
|
within three months
|
Chylothorax
Time Frame: within one month
|
Chylothorax in rate
|
within one month
|
Cardiac arrhythmia
Time Frame: within one month
|
Cardiac arrhythmia in rate
|
within one month
|
Hospital stay
Time Frame: within 60 days
|
Hospital stay in days
|
within 60 days
|
mortality
Time Frame: within 90 days
|
mortality in rate
|
within 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
progression-free survival
Time Frame: within 5 years
|
progression-free survival in rate
|
within 5 years
|
overall survival
Time Frame: within 5 years
|
overall survival in rate
|
within 5 years
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MIE ZYP2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedEsophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer NosGermany
-
University of Wisconsin, MadisonActive, not recruitingResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Tianjin Medical University Cancer Institute and...UnknownStage III Esophageal Cancer | Stage II Esophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...UnknownEsophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0China
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownEsophageal Cancer Stage III | Esophageal Cancer Stage IIBChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States
Clinical Trials on MIE Ivor- Lewis
-
Fudan UniversityShanxi Province Cancer Hospital; The First Hospital of Jilin University; Fujian... and other collaboratorsUnknownEsophageal CancerChina
-
National Taiwan University HospitalUnknownEsophageal Neoplasms | Minimally Invasive | Cancer of Esophagus | Esophagectomy | Surgical Procedures | OperativeTaiwan
-
University Hospitals, LeicesterCompleted
-
Stefan GutknechtNot yet recruitingSwallowing Disorder | Anastomotic Leak EsophagusSwitzerland
-
Xijing Hospital of Digestive DiseasesFirst Affiliated Hospital Xi'an Jiaotong University; Henan Provincial People... and other collaboratorsRecruitingSiewert Type II Adenocarcinoma of Esophagogastric JunctionChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingEsophagogastric Junction CarcinomaChina
-
Sichuan UniversityUnknownPostoperative Complications | Esophageal Cancer | Pulmonary Function | DiaphragmChina
-
Hospital Universitari de BellvitgeUniversity of BarcelonaRecruitingPostoperative Complications | Esophageal Cancer | Esophageal CarcinomaSpain
-
Boston Children's HospitalWithdrawnRegional Anesthesia MorbidityUnited States
-
Shanghai Zhongshan HospitalZhejiang Cancer Hospital; Sun Yat-sen University; Cancer Institute and Hospital... and other collaboratorsRecruitingEsophageal Squamous Cell Carcinoma Stage II | Esophageal Squamous Cell Carcinoma Stage IIIChina